Literature DB >> 18329387

Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling.

Lianyun Li1, Dale W Hailey, Nia Soetandyo, Wei Li, Jennifer Lippincott-Schwartz, Hong-bing Shu, Yihong Ye.   

Abstract

A20 is a tumor necrosis factor (TNF)-inducible zinc finger protein that contains both ubiquitinating and deubiquitinating activities. A20 negatively regulates NFkappaB (nuclear factor kappaB) signaling induced by TNF receptor family and Toll-like receptors, but the mechanism of A20 action is poorly defined. Here we show that a fraction of endogenous and ectopically expressed A20 is localized to an endocytic membrane compartment that is in association with the lysosome. The lysosomal association of A20 requires its carboxy terminal zinc finger domains, but is independent of its ubiquitin-modifying activities. Interestingly, A20 mutants defective in membrane association also contain reduced NFkappaB inhibitory activity. These findings suggest the involvement of a lysosome-associated mechanism in A20-dependent termination of NFkappaB signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329387      PMCID: PMC2587335          DOI: 10.1016/j.bbamcr.2008.01.029

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

Review 1.  NF-kappaB at the crossroads of life and death.

Authors:  Michael Karin; Anning Lin
Journal:  Nat Immunol       Date:  2002-03       Impact factor: 25.606

2.  Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation.

Authors:  Daniel F Legler; Olivier Micheau; Marie-Agnès Doucey; Jürg Tschopp; Claude Bron
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

3.  ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.

Authors:  Jun Huang; Lin Teng; Lixia Li; Ting Liu; Lianyun Li; Danying Chen; Liang-Guo Xu; Zhonghe Zhai; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2004-01-30       Impact factor: 5.157

4.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

Review 5.  TNF-R1 signaling: a beautiful pathway.

Authors:  Guoqing Chen; David V Goeddel
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

6.  Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.

Authors:  M Klinkenberg; S Van Huffel; K Heyninck; R Beyaert
Journal:  FEBS Lett       Date:  2001-06-01       Impact factor: 4.124

7.  The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.

Authors:  H Hsu; J Xiong; D V Goeddel
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

Review 8.  The signaling adaptors and pathways activated by TNF superfamily.

Authors:  Paul W Dempsey; Sean E Doyle; Jeannie Q He; Genhong Cheng
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

9.  Structure of the A20 OTU domain and mechanistic insights into deubiquitination.

Authors:  David Komander; David Barford
Journal:  Biochem J       Date:  2008-01-01       Impact factor: 3.857

10.  Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.

Authors:  Paul C Evans; Huib Ovaa; Maureen Hamon; Peter J Kilshaw; Svetlana Hamm; Stefan Bauer; Hidde L Ploegh; Trevor S Smith
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more
  24 in total

Review 1.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 2.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

3.  A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.

Authors:  Kelly Verhelst; Isabelle Carpentier; Marja Kreike; Laura Meloni; Lynn Verstrepen; Tobias Kensche; Ivan Dikic; Rudi Beyaert
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

4.  LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.

Authors:  Wioletta K Glowacka; Philipp Alberts; Rika Ouchida; Ji-Yang Wang; Daniela Rotin
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 5.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

6.  TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes.

Authors:  Yue Zhai; Peng Lin; Zhuan Feng; Huanyu Lu; Qing Han; Jun Chen; Yang Zhang; Qian He; Gang Nan; Xing Luo; Bin Wang; Fei Feng; Fenyong Liu; Zhinan Chen; Ping Zhu
Journal:  Autophagy       Date:  2018-09-01       Impact factor: 16.016

Review 7.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

8.  The Non-structural Protein NSs of SFTSV Causes Cytokine Storm Through the Hyper-activation of NF-κB.

Authors:  Jumana Khalil; Shintaro Yamada; Yuta Tsukamoto; Hiroto Abe; Masayuki Shimojima; Hiroki Kato; Takashi Fujita
Journal:  Mol Cell Biol       Date:  2020-12-07       Impact factor: 4.272

9.  The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.

Authors:  Lianyun Li; Nia Soetandyo; Qiuyan Wang; Yihong Ye
Journal:  Biochim Biophys Acta       Date:  2008-10-08

10.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.